LIF and CONICET* will work different activities together

Carlos Arques, Diego Bruno and Guillermo Cleti (LIF’s Directors), received Ulises Sedran (CONICET’s Director) and Melisa Bertero (Member of the Investigation Institute of Catalysis and Petrochemistry - CONICET).

 

     In this meeting, they talked about the development and validation of technical analysis for new drugs.
     Both institutions will sign an agreement to progress in these activities.
     CONICET will contribute with equipment, facilities, experience and staff while LIF will contribute with raw material, chemical elements and staff.
     Guillermo Álvarez (LIF’s Trustee) and Roberto Ganin (General Manager) also participated in the meeting.
     Since 2009, LIF and CONICET are members of “Provincial Network for Production, Research and Pharmaceutical Technology”. This network has as main objectives: to coordinate the public production of medicines and to promote innovation and research.

*CONICET: Consejo Nacional de Investigaciones Científicas y Técnicas - National Committee of Scientific and Technical Research.

Meeting at ANLAP

Diego Bruno and Jorge Stettler, participated in a meeting at ANLAP*. They were received by Alfonso Sánchez de León (ANLAP’s President).

  

     In this meeting LIF’s Directors could meet the new ANLAP’s authorities and informed them of the different activities and projects that LIF has been making in the last couple of years such as production of different medicines for National Health Ministry and production of opioids for INC(1).
     María Fernanda Pesado (LEM’s Director) and Martín Grigioni (Member of Health Secretary of Rosario city) also participated in the meeting.
     Sánchez de León informed that ANLAP’s budget for this year will be of $85.000.000 (ARG). Then, he expressed that in 2017 the National Health Ministry will finish the delivery of medicines through CUM(2) and this activity will be made by different provinces.
     Finally, he said that March might be the time for the first meeting of the ANLAP’s Executive Committee (LIF is one of the members of this Committee).

(*) ANLAP: Agencia Nacional de Laboratorios Públicos - National Agency of Public Laboratories.
(1)INC: Instituto Nacional del Cáncer - National Cancer Institute.
(2) CUM: cobertura universal de medicamentos - Medicines Universal Coverage.